![Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Elevated Tumor Markers In Coccidioidomycosis of the Female Genital Tract Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Elevated Tumor Markers In Coccidioidomycosis of the Female Genital Tract](http://www.swjpcc.com/storage/manuscripts/volume-8/issue-3-march-2014/179-13/179-13%20Table1.jpg?__SQUARESPACE_CACHEVERSION=1393872223063)
Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Elevated Tumor Markers In Coccidioidomycosis of the Female Genital Tract
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg?width=800&height=600&carousel=1)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e428395a-6575-43f1-bbb1-57200247edee/gr1_lrg.jpg)
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology
![Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice - ScienceDirect Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009912008001161-gr1.jpg)
Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice - ScienceDirect
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig5_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1983/nejm_1983.309.issue-15/nejm198310133091503/20130822/images/img_medium/nejm198310133091503_t1.jpeg)
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM
![Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825813010147-t1.jpg)